ICM
GIL icon

Invenomic Capital Management’s Gildan GIL Stock Holding History

Invenomic Capital Management’s Portfolio GIL Stock Details GIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-26,118
Closed -$405K – 155
2020
Q2 		$405K Hold
26,118
– – 0.3% 100
2020
Q1 		$333K Buy
+26,118
New +$630K 0.27% 92

Other funds holding GIL

JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
TCAM
Turtle Creek Asset Management Toronto, Ontario, Canada $2.67B AUM 0.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return

Invenomic Capital Management's GIL Position: Q3 2020 in Review

Invenomic Capital Management sold out of Gildan (GIL) in Q3 2020, closing a stake of 26,118 shares — an estimated $405K sold.

Invenomic Capital Management first reported a position in GIL in Q1 2020 and held it in 2 quarters. The position peaked at $405K in Q2 2020. 188 funds tracked by Wall St. Rank hold GIL as of Q3 2020.

  • Invenomic Capital Management reported no remaining Gildan position as of Q3 2020 after selling out during the quarter.
  • Invenomic Capital Management sold 26,118 Gildan shares in Q3 2020, an estimated $405K.
  • Invenomic Capital Management first reported a position in Gildan in Q1 2020 and held it in 2 quarters.
  • Invenomic Capital Management's Gildan position peaked at $405K in Q2 2020.
  • 188 funds tracked by Wall St. Rank held Gildan as of Q3 2020.

Based on Invenomic Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.